Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baihe Gujin Tablets versus Yangyin Qingfei Pills for post-cold cough
ChiCTR2200060141Phase 4Not yet recruiting
- Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Gujin Granule and Yangyin Qingfei Wan in postinfectious cough (2 arms), sponsored by Beijing Hospital of Traditional Chinese Medicine. Primary endpoint: Cough visual analog score. Planned start Mar 2022; status: not yet recruiting.
02
Drugs
Gujin GranuleYangyin Qingfei Wan
03
Conditions
postinfectious cough
Beyond the preview
Go deeper on ChiCTR2200060141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200060141.